AU1455292A - Soluble glucans - Google Patents

Soluble glucans

Info

Publication number
AU1455292A
AU1455292A AU14552/92A AU1455292A AU1455292A AU 1455292 A AU1455292 A AU 1455292A AU 14552/92 A AU14552/92 A AU 14552/92A AU 1455292 A AU1455292 A AU 1455292A AU 1455292 A AU1455292 A AU 1455292A
Authority
AU
Australia
Prior art keywords
soluble glucans
glucans
soluble
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14552/92A
Inventor
Nicholas R. Diluzio
Rose Mcnamee
David L Williams
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bioglucans LP
Original Assignee
Bioglucans LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioglucans LP filed Critical Bioglucans LP
Publication of AU1455292A publication Critical patent/AU1455292A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08BPOLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0024Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid beta-D-Glucans; (beta-1,3)-D-Glucans, e.g. paramylon, coriolan, sclerotan, pachyman, callose, scleroglucan, schizophyllan, laminaran, lentinan or curdlan; (beta-1,6)-D-Glucans, e.g. pustulan; (beta-1,4)-D-Glucans; (beta-1,3)(beta-1,4)-D-Glucans, e.g. lichenan; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/04Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Materials Engineering (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU14552/92A 1991-02-01 1992-01-31 Soluble glucans Abandoned AU1455292A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64952791A 1991-02-01 1991-02-01
US649527 1991-02-01

Publications (1)

Publication Number Publication Date
AU1455292A true AU1455292A (en) 1992-09-07

Family

ID=24605186

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14552/92A Abandoned AU1455292A (en) 1991-02-01 1992-01-31 Soluble glucans

Country Status (2)

Country Link
AU (1) AU1455292A (en)
WO (1) WO1992013896A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1991003495A1 (en) * 1989-09-08 1991-03-21 Alpha Beta Technology, Inc. Method for producing soluble glucans
US5622939A (en) * 1992-08-21 1997-04-22 Alpha-Beta Technology, Inc. Glucan preparation
US5488040A (en) * 1989-09-08 1996-01-30 Alpha-Beta Technology, Inc. Use of neutral soluble glucan preparations to stimulate platelet production
US5811542A (en) * 1989-09-08 1998-09-22 Alpha-Beta Technology, Inc. Method for producing soluble glucans
US5622940A (en) * 1994-07-14 1997-04-22 Alpha-Beta Technology Inhibition of infection-stimulated oral tissue destruction by β(1,3)-glucan
US6117850A (en) * 1995-08-28 2000-09-12 The Collaborative Group, Ltd. Mobilization of peripheral blood precursor cells by β(1,3)-glucan
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
US6046323A (en) * 1997-07-29 2000-04-04 The Collaborative Group, Ltd. Conformations of PPG-glucan
AU6261999A (en) 1998-09-25 2000-04-17 Collaborative Group, Ltd., The Very high molecular weight beta-glucans
US6369216B1 (en) 1998-09-25 2002-04-09 Biopolymer Engineering Pharmaceutical, Inc. Very high molecular weight β-glucans
US7101544B1 (en) 1999-07-21 2006-09-05 Kabushiki Kaisha Yakult Honsha Cholesterol-lowering agents, secondary bile acid production inhibitors, and foods and drinks
US6632459B2 (en) 2000-12-11 2003-10-14 Nutricia N.V. Chlorogenic acid and an analog thereof for immune system stimulation
LT6145B (en) 2014-04-14 2015-04-27 Uab "Biocentras" Therapeutic composition of beta-glucans modulating human immune system and initiating destruction of cancer cells

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3985727A (en) * 1975-03-28 1976-10-12 Schering Corporation Aminoglycoside antibiotics
FR2447193A1 (en) * 1979-01-25 1980-08-22 Unicler USE OF PICHIA OR PICHIA EXTRACTS AS A MEDICINE.
SE466289B (en) * 1984-09-19 1992-01-27 James Hoffman MACROPHAGIMALLY STIMULATING COMPOSITION TAKING PROCEDURE BEFORE ITS PREPARATION
US4739046A (en) * 1985-08-19 1988-04-19 Luzio Nicholas R Di Soluble phosphorylated glucan
JPH0692441B2 (en) * 1986-03-03 1994-11-16 株式会社林原生物化学研究所 β-D-glucan, production method and use thereof

Also Published As

Publication number Publication date
WO1992013896A1 (en) 1992-08-20

Similar Documents

Publication Publication Date Title
AU6018194A (en) Easy intubator
AU1655192A (en) Antivizal dibenzothiazepinone derivatives
AU1644092A (en) Rapidly soluble solid preparation
AU655472B2 (en) Imidazodiazepines
AU653847B2 (en) Benzodioxanderivate
AU654362B2 (en) Pyrrolopyrazines
AU1782292A (en) Gridbeam
AU2135292A (en) Cyanophenylpyrroles
AU1455292A (en) Soluble glucans
AU2636292A (en) Anti-alpha6-integrin-antibodies
AU1556892A (en) 2-substituted-2-imidazolines
AU1080292A (en) Ige-receptor-antibodies
AU1033992A (en) 3-quinuclidine derivatives
AU2586192A (en) Imaginograph
AU1752492A (en) Diamino-alpha-alkylstilbenes
AU647640B2 (en) Quinolin-2-yl-methoxybenzylhydroxyureas
AU2686592A (en) Tetraphenylporphyn derivatives
AU2979992A (en) Quinolylmethoxyphenyl-acetamides
AU3018192A (en) Sulfonimidamides
AU658903B2 (en) Snake-controlling agent
AU1153892A (en) Pyrimidinyl- and triazinylsalicyl- and -picolinylaldehyde derivatives
AU1624092A (en) Mopheads
AU2521192A (en) Polyolefin-polyamine-N-substituted poly-carbamates
AU1669792A (en) Azabicycloheptanone
AU1588892A (en) Watch-strap